Sage Project Podcast Podcast By Sage Project cover art

Sage Project Podcast

Sage Project Podcast

By: Sage Project
Listen for free

Clinical evidence podcast generated from curated article reviews.
Episodes
  • Sage ID Briefing (2026-03-02): Comparing Generative Artificial Intelli, The Role of beta-Lactam Antibiotics in Treating, and Healthcare resource...

    Sage ID Briefing (2026-03-02): Comparing Generative Artificial Intelli, The Role of beta-Lactam Antibiotics in Treating, and Healthcare resource...
    Feb 26 2026
    This episode reviews 7 recent papers with practical clinical takeaways. Covered in this episode: - Comparing Generative Artificial Intelli - The Role of beta-Lactam Antibiotics in Treating - Healthcare resource utilization outcom - CID Marzolini Is TDM of Long Acting Cabotgravir - Therapeutic Drug Monitoring of Long-Acting Ca - Epi of IFD in heart transplants - Clinical Epi and micro of orbital cellulit Educational only. Not medical advice.
    Show more Show less
    1 hr and 1 min
  • 2026-03-02 | CID Alshanqeeti 2026 Comparing Generative Artificial Intelli

    2026-03-02 | CID Alshanqeeti 2026 Comparing Generative Artificial Intelli
    Feb 26 2026
    Welcome everyone to journal club. Today we're diving into a really timely paper about using artificial intelligence to help identify catheter-associated urinary tract infections, or CAUTIs, in the hospital setting. Before we get rolling, I need to say that this discussion is educational only and not medical advice. We're here to critically appraise the evidence together. So we're looking at one paper today - Alshanqeeti 2026 - which evaluates whether GPT-4o, that large language model from OpenAI, can actually do the work of infection surveillance specialists? Exactly. And it's a fascinating question because if GenAI can help us identify these hospital-acquired infections reliably, that could potentially free up a lot of human time and reduce costs. But let's start with the basics. What kin
    Show more Show less
    6 mins
  • 2026-03-02 | CID Dousa 2026 The Role of beta-Lactam Antibiotics in Treating

    2026-03-02 | CID Dousa 2026 The Role of beta-Lactam Antibiotics in Treating
    Feb 26 2026
    Next paper, 2 of 7. Let us shift to "CID Dousa 2026 The Role of beta-Lactam Antibiotics in Treating" and pressure-test what actually matters clinically. So right off the bat, this isn't a randomized trial or a cohort study with actual patient data? Correct. It's explicitly a narrative or expert-synthesis review article published in CID in January 2026. What that means is the authors are pulling together existing evidence and clinical experience rather than conducting original research with enrolled patients. So we need to think about this differently than we would a trial.
    Show more Show less
    12 mins
No reviews yet